| |
| |
|
| Insider
Information: |
Nandabalan Krishnan |
| Relationship: |
Director, 10% Owner |
| City: |
New Haven |
| State: |
CT |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
0 |
|
|
Indirect Shares
|
8,546,750 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$15,469,618 |
|
|
| Total
Shares |
8,546,750 |
|
|
| Total
Value |
$15,469,618 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
1
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
1
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
-1.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -47.9%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Bioxcel Therapeutics Inc |
BTAI |
Director, 10% Owner |
2023-04-06 |
0 |
2023-04-06 |
8,546,750 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
13 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| BTAI |
Bioxcel Therapeutics Inc |
Director |
– • • |
2023-04-06 |
4 |
AS |
$17.32 |
$1,039,200 |
D/D |
(60,000) |
0 |
0 |
% |
|
| BTAI |
Bioxcel Therapeutics Inc |
Director |
– • • |
2023-04-06 |
4 |
OE |
$0.41 |
$24,600 |
D/D |
60,000 |
60,000 |
0 |
- |
|
| BTAI |
Bioxcel Therapeutics Inc |
Director |
– • • |
2022-11-11 |
4 |
AS |
$15.00 |
$488,250 |
D/D |
(32,550) |
0 |
0 |
% |
|
| BTAI |
Bioxcel Therapeutics Inc |
Director |
– • • |
2022-11-11 |
4 |
OE |
$0.41 |
$13,346 |
D/D |
32,550 |
32,550 |
0 |
- |
|
| BTAI |
Bioxcel Therapeutics Inc |
Director |
– • • |
2022-11-10 |
4 |
AS |
$15.00 |
$411,750 |
D/D |
(27,450) |
0 |
0 |
% |
|
| BTAI |
Bioxcel Therapeutics Inc |
Director |
– • • |
2022-11-10 |
4 |
OE |
$0.41 |
$11,255 |
D/D |
27,450 |
27,450 |
0 |
- |
|
| BTAI |
Bioxcel Therapeutics Inc |
Director |
– • – |
2021-06-25 |
4 |
S |
$30.83 |
$14,589,493 |
I/I |
(473,250) |
8,546,750 |
0 |
% |
|
| BTAI |
Bioxcel Therapeutics Inc |
Director |
– • – |
2020-07-24 |
4 |
A |
$60.76 |
$4,860,800 |
D/D |
80,000 |
80,000 |
0 |
- |
|
| BTAI |
Bioxcel Therapeutics Inc |
Director |
– • – |
2020-07-24 |
4 |
D |
$60.76 |
$9,721,600 |
I/I |
(160,000) |
9,020,000 |
0 |
- |
|
| BTAI |
Bioxcel Therapeutics Inc |
Director |
– • • |
2020-02-24 |
4 |
D |
$30.08 |
$9,024,000 |
I/I |
(300,000) |
9,180,000 |
0 |
- |
|
| BTAI |
Bioxcel Therapeutics Inc |
Director |
– • – |
2019-04-01 |
4 |
GA |
$0.00 |
$0 |
I/I |
1,000 |
1,000 |
0 |
- |
|
| BTAI |
Bioxcel Therapeutics Inc |
Director |
– • – |
2019-04-01 |
4 |
GD |
$0.00 |
$0 |
D/D |
1,000 |
0 |
0 |
- |
|
| BTAI |
Bioxcel Therapeutics Inc |
Director |
– • • |
2018-11-29 |
4 |
B |
$4.92 |
$4,915 |
D/D |
1,000 |
1,000 |
3.84 |
- |
|
13 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
